Jean L Rouleau
Overview
Explore the profile of Jean L Rouleau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
222
Citations
13772
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kondo T, Jhund P, Anand I, Claggett B, Desai A, Docherty K, et al.
JACC Heart Fail
. 2025 Mar;
PMID: 40088233
Background: Recent trials of new heart failure (HF) treatments suggest the effect of therapy may vary by N-terminal pro-B type natriuretic peptide (NT-proBNP) level. Objectives: The authors examined the efficacy...
2.
Yang M, Kondo T, Dewan P, Desai A, Lam C, Lefkowitz M, et al.
Circ Heart Fail
. 2025 Mar;
:e011598.
PMID: 40026147
Background: How different combinations of comorbidities influence risk at the patient level and population level in patients with heart failure with mildly reduced ejection fraction/heart failure with preserved ejection fraction...
3.
Solano S, Yang M, Tolomeo P, Kondo T, Shen L, Jhund P, et al.
J Am Heart Assoc
. 2024 Dec;
14(1):e037782.
PMID: 39719408
Background: The importance of nutritional status is underappreciated in patients with heart failure (HF). This study aimed to describe the range of the prognostic nutrition index (PNI), and the clinical...
4.
Foa A, Pabon M, Braunwald E, Jering K, Vaduganathan M, Claggett B, et al.
Eur J Heart Fail
. 2024 Dec;
PMID: 39694540
Aims: The temporal changes in clinical profiles and outcomes of high-risk myocardial infarction survivors enrolled in clinical trials are poorly described. This study compares mortality rates, baseline characteristics, and the...
5.
Mc Causland F, Vaduganathan M, Claggett B, Gori M, Jhund P, McGrath M, et al.
JACC Heart Fail
. 2024 Nov;
13(1):105-114.
PMID: 39570234
Background: Lower estimated glomerular filtration rate (eGFR) may be one of the major reasons for hesitation or failure to initiate potentially beneficial therapies in patients with heart failure (HF). Objectives:...
6.
Gupta S, Butt J, McMurray E, Talebi A, Matsumoto S, Rizkala A, et al.
Eur J Heart Fail
. 2024 Nov;
PMID: 39563094
Aims: Beta-blockers may inhibit neprilysin activity and conversely, neprilysin inhibition may have a sympatho-inhibitory action. Consequently, sacubitril/valsartan may have a greater effect in patients not receiving a beta-blocker compared to...
7.
Shen L, Dewan P, Ferreira J, Cunningham J, Jhund P, Anand I, et al.
Circulation
. 2024 Oct;
150(24):1913-1927.
PMID: 39429145
Background: Cognitive impairment is common in patients with heart failure and preserved ejection fraction but its clinical correlates and prognostic associations are poorly understood. Methods: We analyzed cognitive function, using...
8.
Matsumoto S, Shen L, Henderson A, Bohm M, Desai A, Kober L, et al.
J Am Coll Cardiol
. 2024 Sep;
84(18):1685-1700.
PMID: 39320292
Background: Hypotension is an important clinical problem in heart failure (HF). Objectives: This study sought to examine the association between asymptomatic vs symptomatic hypotension and outcomes in PARADIGM-HF (Prospective Comparison...
9.
Matsumoto S, Henderson A, Shen L, Kondo T, Yang M, Campbell R, et al.
Eur J Heart Fail
. 2024 Aug;
27(1):124-139.
PMID: 39215677
Aims: In the absence of randomized trial evidence, we performed a large observational analysis of the association between beta-blocker (BB) use and clinical outcomes in patients with heart failure (HF)...
10.
Curtain J, Pfeffer M, Braunwald E, Claggett B, Granger C, Kober L, et al.
JAMA Cardiol
. 2024 Aug;
9(10):928-933.
PMID: 39110471
Importance: Sudden death is a leading cause of death after acute myocardial infarction (AMI). The Prospective ARNi vs ACE Inhibitor Trial to Determine Superiority in Reducing Heart Failure Events After...